Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Despite Cures Boost, Lingering Appropriations Means FDA Device Funding Still An Unknown For 2017

Executive Summary

With the president's signature of the 21st Century Cures Act, US FDA has $20m in FY 2017 to begin carrying out a multitude of reforms in the law. Meanwhile, the regular budget appropriated by Congress will remain at 2016 levels through April. But as of Dec. 14, device center director Jeff Shuren said he did not know the amounts specifically that would go to his center. And now FDA supporters wonder if the Cures dollars will be tapped to do regular agency work.

You may also be interested in...



Rep. Shimkus, Author Of 'Cures' Device Provisions, Joins Exodus Of Republicans Retiring In 2020 From US House

Illinois Rep. John Shimkus, a well-known pro-medtech industry bill sponsor, announced on 30 August his plans for a January 2020 retirement. He joins at least 15 Republican House members who recently said they are also ending their Capitol Hill careers, leaving six vacancies on the US House Energy and Commerce and Ways and Means panels prior to the 2020 elections.

Congress To Focus On Cures And MACRA Oversight, MDUFA In 2017

Congressional health committees will spend time in 2017 focusing on oversight of agencies' implementation of the 21st Century Cures Act and the Medicare Authorization and CHIP Reauthorization Act, as well as five-year reauthorization of the medical device and prescription drug user fee acts.

Senate Adopts Cures Bill By Big Margin; FDA Could Tap $20m More In 2017

The Senate approved the same 21st Century Cures bill passed by the House last week on a 94-5 tally; the bill is expected to be quickly signed by President Obama. Provisions for extra dollars for FDA in the bill means that even with a plan by Congress to adopt a continuing resolution this week freezing FDA funding until April 28, the agency can rely on an additional $20 million set aside for it in Cures in the new year.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT104212

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel